Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 111, Issue 6, 2013, Pages 841-845

  Loh, Joshua P ^a   Pendyala, Lakshmana K ^a   Kitabata, Hironori ^a   Torguson, Rebecca ^a   Chen, Fang ^a   Kent, Kenneth M ^a   Satler, Lowell F ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PRASUGREL;

ACUTE CORONARY SYNDROME; ADULT; AGE; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; INTENSIVE CARE; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACUTE CORONARY SYNDROME; ASPIRIN; CHI-SQUARE DISTRIBUTION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; THIOPHENES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84884211767     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.11.058     Document Type: Article

References (17)

1. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, and H.H. Ting 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 e574 e651
2. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, S. Chrolavicius, I. Copland, K.A. Fox Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
3. S.R. Steinhubl, P.B. Berger, J.T. Mann III, E.T. Fry, A. DeLago, C. Wilmer, E.J. Topol CREDO Investigators (Clopidogrel for the Reduction of Events During Observation) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
4. S. Matetzky, B. Shenkman, V. Guetta, M. Shechter, R. Bienart, I. Goldenberg, I. Novikov, H. Pres, N. Savion, D. Varon, and H. Hod Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
5. T. Geisler, H. Langer, M. Wydymus, K. Göhring, C. Zürn, B. Bigalke, K. Stellos, A.E. May, and M. Gawaz Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Eur Heart J 27 2006 2420 2425
6. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, J.T. Brandt, J.R. Walker, E.M. Antman, W. Macias, E. Braunwald, and M.S. Sabatine Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
7. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
8. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
9. J.T. Brandt, C.D. Payne, S.D. Wiviott, G. Weerakkody, N.A. Farid, D.S. Small, J.A. Jakubowski, H. Naganuma, and K.J. Winters A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 2007 66.e9 66.e16
10. S.D. Wiviott, D. Trenk, A.L. Frelinger, M. O'Donoghue, F.J. Neumann, A.D. Michelson, D.J. Angiolillo, H. Hod, G. Montalescot, D.L. Miller, J.A. Jakubowski, R. Cairns, S.A. Murphy, C.H. McCabe, E.M. Antman, E. Braunwald PRINCIPLE-TIMI 44 Investigators Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation 116 2007 2923 2932
11. C.D. Payne, Y.G. Li, J.T. Brandt, J.A. Jakubowski, D.S. Small, N.A. Farid, D.E. Salazar, and K.J. Winters Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects Platelets 19 2008 275 281
12. D.J. Angiolillo, J.F. Saucedo, R. Deraad, A.L. Frelinger, P.A. Gurbel, T.M. Costigan, J.A. Jakubowski, C.K. Ojeh, M.B. Effron SWAP Investigators Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study J Am Coll Cardiol 56 2010 1017 1023
13. D. Alexopoulos, K.C. Theodoropoulos, E.F. Stavrou, I. Xanthopoulou, G. Kassimis, G. Tsigkas, A. Damelou, P. Davlouros, G. Hahalis, and A. Athanassiadou Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction Cardiovasc Drugs Ther 26 2012 393 400
14. M.T. Roe, P.W. Armstrong, K.A. Fox, H.D. White, D. Prabhakaran, S.G. Goodman, J.H. Cornel, D.L. Bhatt, P. Clemmensen, F. Martinez, D. Ardissino, J.C. Nicolau, W.E. Boden, P.A. Gurbel, W. Ruzyllo, A.J. Dalby, D.K. McGuire, J.L. Leiva-Pons, A. Parkhomenko, S. Gottlieb, G.O. Topacio, C. Hamm, G. Pavlides, A.R. Goudev, A. Oto, C.D. Tseng, B. Merkely, V. Gasparovic, R. Corbalan, M. Cintezǎ, R.C. McLendon, K.J. Winters, E.B. Brown, Y. Lokhnygina, P.E. Aylward, K. Huber, J.S. Hochman, E.M. Ohman TRILOGY ACS Investigators Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
15. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, F. Van de Werf, K.W. Mahaffey, R.M. Califf, and R.A. Harrington Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
16. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King III, E.M. Ohman, and G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368
17. S.V. Rao, J.G. Jollis, R.A. Harrington, C.B. Granger, L.K. Newby, P.W. Armstrong, D.J. Moliterno, L. Lindblad, K. Pieper, E.J. Topol, J.S. Stamler, and R.M. Califf Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562